CarbIDOpa 是一种选择性芳香烃受体(AhR)调节剂，是外周型脱羧酶抑制剂，抑制胰腺癌细胞和肿瘤生长，可用于帕金森病的研究。

Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.

28860-95-9

C10H14N2O4

226.232

Lodosyn;(S)-(-)-Carbidopa;卡比多巴

DMSO:4.5 mg/mL (20 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years